
Estradiol hemihydrate NEW
Price | Get Latest Price | |
Package | 1kg | 25kg |
Min. Order: | 1kg |
Supply Ability: | 500kg |
Update Time: | 2025-06-19 |
Product Details
Product Name: Estradiol hemihydrate | CAS No.: 35380-71-3 |
Min. Order: 1kg | Purity: 99.9% |
Supply Ability: 500kg | Release date: 2025/06/19 |
?Estradiol Hemihydrate (CAS 35380-71-3)?
Google Keywords: Estradiol Hemihydrate CAS 35380-71-3, Estrogen API Manufacturing, HRT Drug Synthesis, Hormone Replacement Therapy, GMP Pharmaceutical Intermediates
?? ?Product Overview?
?Estradiol Hemihydrate? (CAS 35380-71-3) is a semi-hydrated crystalline form of estradiol, a potent estrogen hormone critical for ?hormone replacement therapy (HRT)?, ?contraceptive formulations?, and ?menopausal symptom management?. As a high-purity intermediate, it enables precise synthesis of estradiol-based APIs, ensuring therapeutic efficacy in regulating endocrine functions and reproductive health.
?Primary Function?: Key intermediate for producing estradiol APIs and formulations with controlled bioavailability.
?Applications?: HRT drug development, contraceptive manufacturing, and treatment of estrogen deficiency disorders.
? ?Key Advantages?
?? ?Ultra-High Purity? | ≥99.0% (HPLC/GC verified) | Complies with ICH Q11 guidelines for pharmaceutical intermediates.
?? ?Enhanced Stability? | Hemihydrate form ensures optimal shelf-life and resistance to degradation under controlled conditions.
?? ?Regulatory Readiness? | Fully characterized (NMR, FTIR, XRPD) to support FDA/EMA filings and GMP compliance.
?? ?Applications?
?API Manufacturing?: Essential for synthesizing estradiol in HRT drugs, transdermal patches, and oral tablets.
?Contraceptive Formulations?: Used in combination therapies to regulate ovulation and hormonal balance.
?Clinical Research?: Supports studies on estrogen receptor modulation and osteoporosis prevention.
?? ?Quality Assurance?
?Testing Methods?: HPLC, GC, NMR, FTIR, and X-ray powder diffraction (XRPD) for structural validation and impurity profiling.
?Standards?: Meets USP <1086>, EP 10.0, and ISO 9001:2015 certified production protocols.
?? ?Market Trends?
The ?global hormone replacement therapy market? is projected to exceed ?$33 billion by 2030? (CAGR 6.3%), driven by aging populations, rising awareness of menopausal health, and demand for personalized estrogen therapies. Estradiol intermediates like this hemihydrate form are pivotal in scaling production of FDA-approved HRT solutions.
Accelerate your hormone therapy production with Estradiol Hemihydrate – precision-crafted for purity, stability, and regulatory alignment.
Company Profile Introduction
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$5.00/1KG |
VIP1Y
|
Wuhan JiyunZen Tech Co., Ltd.
|
2025-05-30 | |
$4900.00/100mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2025-04-27 | |
$10.00/1KG |
VIP5Y
|
Hebei Chuanghai Biotechnology Co,.LTD
|
2024-08-20 | |
$0.00/25kg |
PUSHAN INDUSTRIAL (SHAANXI) CO.,LTD
|
2024-06-13 | ||
$10.00/1kg |
Nantong Guangyuan Chemicl Co,Ltd
|
2023-11-01 | ||
$0.00/100g/Bag |
VIP5Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2021-06-03 | |
$1.00/1g |
Cangzhou Wanyou New Material Technology Co.,Ltd
|
2019-07-25 | ||
$7.00/1KG |
VIP7Y
|
Career Henan Chemical Co
|
2019-05-23 |
+86-+undefined-+86 13343427080
sales@biocarchem.com